Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $695,014 (100.0% shares, 0.0% debt)

Holdings (36)

APLS APELLIS PHARMACEUTICALS INC 30.8%
Value ($000) $214,370 Shares 3,250,000 Est. Cost $48.31 Unrealized +19.4%
CHINOOK THERAPEUTICS INC 8.5%
Value ($000) $59,072 Shares 2,551,703 Est. Cost $16.88 Unrealized
VERONA PHARMA PLC 7.1%
Value ($000) $49,557 Shares 2,468,000 Est. Cost $17.59 Unrealized
CYMABAY THERAPEUTICS INC 5.7%
Value ($000) $39,858 Shares 4,570,918 Est. Cost $7.72 Unrealized
RCUS ARCUS BIOSCIENCES INC 5.7%
Value ($000) $39,617 Shares 2,172,000 Est. Cost $33.27 Unrealized -42.6%
VRDN VIRIDIAN THERAPEUTICS INC 4.3%
Value ($000) $30,146 Shares 1,185,000 Est. Cost $25.79 Unrealized +24.3%
ROIV ROIVANT SCIENCES LTD 4.1%
Value ($000) $28,812 Shares 3,904,000 Est. Cost $8.23 Unrealized 0.0%
MIRATI THERAPEUTICS INC 4.0%
Value ($000) $27,885 Shares 750,000 Est. Cost $52.54 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 3.9%
Value ($000) $27,341 Shares 759,898 Est. Cost $25.60 Unrealized +68.6%
BBIO BRIDGEBIO PHARMA INC 3.2%
Value ($000) $22,187 Shares 1,338,160 Est. Cost $30.51 Unrealized -61.8%
TNDM TANDEM DIABETES CARE INC 2.8%
Value ($000) $19,287 Shares 474,929 Est. Cost $54.82 Unrealized -24.5%
AEROVATE THERAPEUTICS INC 1.8%
Value ($000) $12,540 Shares 621,712 Est. Cost $29.30 Unrealized
JASPER THERAPEUTICS INC 1.7%
Value ($000) $11,552 Shares 6,382,500 Est. Cost $1.81 Unrealized
TVTX TRAVERE THERAPEUTICS INC 1.6%
Value ($000) $11,133 Shares 495,000 Est. Cost $21.26 Unrealized 0.0%
ALPINE IMMUNE SCIENCES INC 1.3%
Value ($000) $9,279 Shares 1,202,000 Est. Cost $7.20 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 1.2%
Value ($000) $8,595 Shares 499,996 Est. Cost $30.23 Unrealized -35.7%
ITEOS THERAPEUTICS INC 1.2%
Value ($000) $8,112 Shares 596,000 Est. Cost $18.03 Unrealized
DYN DYNE THERAPEUTICS INC 1.1%
Value ($000) $7,983 Shares 692,945 Est. Cost $12.99 Unrealized 0.0%
XLO XILIO THERAPEUTICS INC 1.1%
Value ($000) $7,687 Shares 2,425,000 Est. Cost $2.77 Unrealized +13.1%
VKTX VIKING THERAPEUTICS INC 0.9%
Value ($000) $6,244 Shares 375,000 Est. Cost $4.46 Unrealized +131.4%
VERA VERA THERAPEUTICS INC 0.9%
Value ($000) $6,169 Shares 795,000 Est. Cost $14.69 Unrealized -47.4%
89BIO INC 0.9%
Value ($000) $6,092 Shares 400,000 Est. Cost $12.86 Unrealized
RNAM AVIDITY BIOSCIENCES INC 0.8%
Value ($000) $5,864 Shares 382,000 Est. Cost $26.66 Unrealized -17.5%
INTRA-CELLULAR THERAPIES INC 0.7%
Value ($000) $5,128 Shares 94,700 Est. Cost $46.53 Unrealized
GERN GERON CORP 0.7%
Value ($000) $4,943 Shares 2,278,000 Est. Cost $2.84 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 0.7%
Value ($000) $4,668 Shares 577,000 Est. Cost $12.69 Unrealized 0.0%
ANNX ANNEXON INC 0.7%
Value ($000) $4,582 Shares 1,190,000 Est. Cost $5.50 Unrealized 0.0%
GLYCOMIMETICS INC 0.5%
Value ($000) $3,780 Shares 3,000,000 Est. Cost $1.26 Unrealized
RENEO PHARMACEUTICALS INC 0.4%
Value ($000) $2,512 Shares 420,000 Est. Cost $5.98 Unrealized
GOSS GOSSAMER BIO INC 0.4%
Value ($000) $2,467 Shares 1,958,069 Est. Cost $9.60 Unrealized -80.1%
GPCR STRUCTURE THERAPEUTICS INC 0.3%
Value ($000) $2,229 Shares 93,692 Est. Cost $23.79 Unrealized
BBIO BRIDGEBIO PHARMA INC 0.2%
Value ($000) $1,658 Shares 100,000 Est. Cost $30.51 Unrealized -61.8%
STOK STOKE THERAPEUTICS INC 0.2%
Value ($000) $1,547 Shares 185,669 Est. Cost $27.91 Unrealized -67.7%
CNTA CENTESSA PHARMACEUTICALS PLC 0.2%
Value ($000) $1,525 Shares 396,000 Est. Cost $3.85 Unrealized
VECTIVBIO HLDG AG 0.0%
Value ($000) $300 Shares 35,259 Est. Cost $8.51 Unrealized
PIERIS PHARMACEUTICALS INC 0.0%
Value ($000) $294 Shares 301,490 Est. Cost $0.98 Unrealized